A 24-week Safety, Efficacy, Pharmacodynamic, and Pharmacokinetic Study of Teduglutide in Japanese Pediatric Subjects, Aged 1 Year Through 15 Years, With Short Bowel Syndrome Who Are Dependent on Parenteral Support

Trial Profile

A 24-week Safety, Efficacy, Pharmacodynamic, and Pharmacokinetic Study of Teduglutide in Japanese Pediatric Subjects, Aged 1 Year Through 15 Years, With Short Bowel Syndrome Who Are Dependent on Parenteral Support

Recruiting
Phase of Trial: Phase III

Latest Information Update: 26 Sep 2017

At a glance

  • Drugs Teduglutide (Primary)
  • Indications Short bowel syndrome
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Therapeutic Use
  • Sponsors Shire
  • Most Recent Events

    • 20 Sep 2017 Planned End Date changed from 1 Oct 2017 to 3 Jul 2018.
    • 20 Sep 2017 Planned primary completion date changed from 1 Oct 2017 to 3 Jul 2018.
    • 17 Feb 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top